ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,449Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 323

$625K Total Retail Price of All Prescriptions

Rank: 9 out of 323

1,007 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
25% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 13,810 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
CLOPIDOGREL 1,038 924 1 9
FUROSEMIDE 911 829 2 6
SIMVASTATIN 873 800 3 4
CARVEDILOL 830 723 4 1
METOPROLOL TARTRATE 778 705 5 3
METOPROLOL SUCCINATE 764 706 6 8
WARFARIN SODIUM 742 698 7 5
PLAVIX 694 644 8 12
ENALAPRIL MALEATE 687 606 9 29
ATENOLOL 562 516 10 16
LISINOPRIL 509 431 11 2
DIGOXIN 487 472 12 15
ISOSORBIDE MONONITRATE ER 445 396 13 11
NITROSTAT 353 308 14 21
KLOR-CON M20 328 298 15 24
PRAVASTATIN SODIUM 316 259 16 13
CRESTOR 307 285 17 14
AMLODIPINE BESYLATE 295 278 18 7
HYDROCHLOROTHIAZIDE 293 251 19 18
ATORVASTATIN CALCIUM 266 222 20 10
POTASSIUM CHLORIDE 260 232 21 20
VERAPAMIL ER 242 242 22 62
LOSARTAN POTASSIUM 220 216 23 17
RAMIPRIL 181 134 24 23
DILTIAZEM 24HR ER 174 160 25 33
DIOVAN 170 147 26 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 128 112 27 37
AMIODARONE HCL 121 116 28 22
SPIRONOLACTONE 114 99 29 19
NADOLOL 108 108 30 98
DILTIAZEM 24HR CD 107 92 31 45
EFFIENT 92 87 32 42
OMEPRAZOLE 78 72 33 31
FAMOTIDINE 78 74 33 48
PRADAXA 71 71 35 26
CLONIDINE HCL 69 67 36 41
KLOR-CON M10 68 62 37 91
METOLAZONE 66 63 38 61
MULTAQ 61 52 39 46
QUINAPRIL HCL 59 44 40 60
LEVOTHYROXINE SODIUM 55 55 41 28
DILTIAZEM HCL 53 37 42 70
NIFEDIPINE ER 50 39 43 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 14, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.